Covidien, LP Recalls Puritan Bennett 980 Series Ventilator Due to Manufacturing Assembly Error
Covidien, LP (part of Medtronic) is recalling its Puritan Bennett 980 Series Ventilator due to a capacitor manufacturing assembly error.
Italiano
Covidien, LP (part of Medtronic) is recalling its Puritan Bennett 980 Series Ventilator due to a capacitor manufacturing assembly error.
List of Medical Device recalls in 2022.
Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level. This recall ONLY applies to tubes labeled with “Lot AC13786” and “Exp Dec 2022”. No other lots of this product
Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling thirty three (33) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. Reason for the recall is an Out of specification result observed for the said product, Lot number M008132, “N-nitroso
December 27, 2021 – Padagis US LLC announced today it has issued a voluntary nationwide recall to the consumer/user level of the lots of Nitroglycerin Lingual Spray listed in the table below. Out of an abundance of caution, this product is being recalled from the market due to a complaint received t
Thu, 23 Dec 2021 09:25:39 -0500
Dans le traitement de la dégénérescence maculaire néovasculaire (humide ou exsudative) liée à l’âge (DMLA).
Thu, 23 Dec 2021 09:15:53 -0500
​For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
Thu, 23 Dec 2021 09:06:12 -0500
La cariprazine est indiquée en monothérapie comme suit : Manie : traitement actif des épisodes maniaques ou mixtes associés au trouble bipolaire de type I chez l’adulte. Dépression : traitement actif des épisodes dépressifs associés au trouble bipolaire de type I chez l’adulte.
Wed, 22 Dec 2021 14:30:43 -0500
Vyndaqel is indicated for the treatment of adult patients with cardiomyopathy due to transthyretin-mediated amyloidosis, wild-type or hereditary, to reduce cardiovascular mortality and cardiovascular-related hospitalization.
The FDA is updating information about Getinge’s Maquet/Datascope IABP devices including information about three voluntary recalls.
80.211.154.110